Validation of a Tear-based Screening Assay for Breast Cancer

Status unconfirmed

Conditions studied: Healthy, Breast Cancer, Breast Cancer Female, Health Care Utilization, Health Knowledge, Attitudes, Practice, Health Personnel Attitude, Health Care Acceptability

In brief

This study will explore and better understand the value, usage, and benefits of a tear-based screening test for breast cancer as a supplemental tool for screening mammograms. This tear-based screening test was developed and validated by Namida Lab, Inc., a high complexity Clinical Laboratory Improvement Amendments (CLIA) certified lab.

Key facts

Study ID

NCT04928014

Run by

Namida Lab

People needed

205

Starts

2021-06-01

Expected to finish

2025-12-01

Last updated by the study team

2023-07-03

Who can join

Age: 18 and older, up to 100. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Female over the age of 18 Able to undergo the informed consent process Willingness to comply with all study procedures

You may not qualify if…

• Currently diagnosed or are receiving treatment for breast cancer Have an active eye infection under 18 years of age

Where it is running

• Namida Lab — Fayetteville, Arkansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.